Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New treatment for CMV retinitis in the pipeline at Roche

Oct. 7, 1998

Potent, orally absorbed HIV-1 protease inhibitors selected from series of azadipeptides

Oct. 6, 1998

The PAF antagonist MFH-1 shows potential as an adjunct in the therapy of AIDS

Oct. 6, 1998

New lead anti-HIV compound discovered by Italian university researchers

Oct. 6, 1998

U.S. is country of first launch for DuPont's NNRTI

Oct. 5, 1998

Sarawak MediChem initiates phase Ib trial of (+)-calanolide A

Oct. 2, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

New azapeptide HIV protease inhibitor profiled at ICAAC

Sep. 30, 1998

Novel AIDS therapeutic enters phase I/II testing in South Africa

Sep. 29, 1998

Phase II primate study of 1F7 expanded; clinical testing in sight

Sep. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....